{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T18:28:50Z","timestamp":1778264930239,"version":"3.51.4"},"reference-count":39,"publisher":"Impact Journals, LLC","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,2,6]]},"DOI":"10.18632\/oncotarget.18329","type":"journal-article","created":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T23:10:03Z","timestamp":1496358603000},"page":"9489-9497","source":"Crossref","is-referenced-by-count":6,"title":["Efficacy and safety of Zhibitai in combination with atorvastatin for lipid lowering in patients with coronary heart disease"],"prefix":"10.18632","volume":"9","author":[{"given":"Danyan","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Cardiology, the Second Xiangya Hospital of Central South University, Changsha, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahui","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the Second Xiangya Hospital of Central South University, Changsha, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinghua","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the Second Affiliated Hospital of Nanchang University, Nanchang, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiming","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusheng","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tangdu Hospital, Xi\u2019an, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Chinese Medicine, Huadong Hospital Affiliated to Fudan University, Shanghai, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Chinese Medicine, Beijing Hospital, Beijing, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yushan","family":"Chen","sequence":"additional","affiliation":[{"name":"Center of Cardiology, the First Affiliated Hospital of Henan University of TCM, Zhengzhou, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoping","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, West China Hospital of Sichuan University, Chengdu, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the First People\u2019s Hospital of Yunnan, Kunming, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuiping","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the Second Xiangya Hospital of Central South University, Changsha, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,6,1]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrcardio.2015.28","article-title":"Cardiovascular risk assessment: a global perspective","volume":"12","author":"Qi","year":"2015","journal-title":"Nature Reviews Cardiology"},{"key":"2","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","author":"Third Report of the National Cholesterol Education","year":"2002","journal-title":"Circulation"},{"key":"3","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Cholesterol Treatment Trialists\u2019 CTT Collaboration","year":"2010","journal-title":"Lancet"},{"key":"4","first-page":"1495","article-title":"AHA\/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association","volume":"65","author":"Mosca","year":"2015","journal-title":"Journal of the American College of Cardiology"},{"key":"5","first-page":"3","article-title":"ESC\/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR)","volume":"217","author":"Taskinen","year":"2016","journal-title":"European Heart Journal"},{"key":"6","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins","volume":"366","author":"Treatment","year":"2005","journal-title":"Lancet"},{"key":"7","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1161\/CIRCULATIONAHA.106.624890","article-title":"Risks associated with statin therapy: a systematic overview of randomized clinical trials","volume":"114","author":"Krumholz","year":"2006","journal-title":"Circulation"},{"key":"8","first-page":"70","article-title":"Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease","volume":"341","author":"McCormick","year":"1999","journal-title":"Atorvastatin versus Revascularization Treatment Investigators. New England Journal Medicine"},{"key":"9","first-page":"131","article-title":"Muscle adverse effect and solutions of statin","volume":"20","author":"Wei","year":"2008","journal-title":"Strait Pharmaceutical Journal"},{"key":"10","first-page":"13","article-title":"Clinical study of atorvastatin on carotid artery atherosclerotic plaques in patients with cerebral infraction","volume":"10","author":"Fang","year":"2007","journal-title":"Chinese Journal of Practical Nervous Disease"},{"key":"11","first-page":"1528","article-title":"Adverse reactions of atorvastatin","volume":"30","author":"Jian","year":"2011","journal-title":"Herald of Medicine"},{"key":"12","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1001\/jama.2011.860","article-title":"Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis","volume":"305","author":"de Lemos","year":"2011","journal-title":"JAMA"},{"key":"13","first-page":"937","article-title":"Chinese guidelines on prevention and treatment of dyslipidemia in adults","volume":"31","author":"Joint committee for developing Chinese guidelines on prevention and treatment of dyslipidemia in adults","year":"2016","journal-title":"Chinese Circulation Journal"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA. 2001; 285:2486\u20132497.","DOI":"10.1001\/jama.285.19.2486"},{"key":"15","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1056\/NEJMoa1001282","article-title":"Effects of combination lipid therapy in type 2 diabetes mellitus","volume":"362","author":"Bigger","year":"2010","journal-title":"New England Journal Medicine"},{"key":"16","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"Weintraub","year":"2011","journal-title":"New England Journal Medicine"},{"key":"17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1300955","article-title":"Effects of extended-release niacin with laropiprant in high-risk patients","volume":"371","author":"Armitage","year":"2014","journal-title":"New England Journal Medicine"},{"key":"18","first-page":"113","article-title":"A clinical study of hyperlipemia by simvastatin combined shanzha jiangzhi decoction therapy","volume":"11","author":"Fu","year":"2009","journal-title":"Journal of Liaoning University of TCM"},{"key":"19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1142\/S0192415X05002606","article-title":"Hawthorn: potential roles in cardiovascular disease","volume":"33","author":"Shao","year":"2005","journal-title":"Am J Chin Med"},{"key":"20","first-page":"387","article-title":"Research and application progress of red yeast rice for lowering the blood chelosterol level","volume":"35","author":"Wu","year":"2014","journal-title":"Science and Technology of Food Industry"},{"key":"21","first-page":"392","article-title":"Comparative study of the efficacy and safety of Zhibitai and atorvastatin","volume":"49","author":"Zhao","year":"2010","journal-title":"China Journal of Internal Medicine"},{"key":"22","first-page":"213","article-title":"Study on Bioactive Constituents of Xuezhikang","author":"Xie","year":"1998","journal-title":"China Academic Journal Electronic Publishing House"},{"key":"23","first-page":"77","article-title":"Observation of curative effect of zhibitai in treating hyperlipidemia","volume":"16","author":"Hao","year":"2013","journal-title":"Chinese Journal of Practical Nervous Disease"},{"key":"24","first-page":"320","article-title":"Observation of curative effect of zhibitai capsules in 40 patients with dislipidemia","volume":"27","author":"Xiang","year":"2013","journal-title":"Journal of Hubei University of Science and Technology (Medicine Science)"},{"key":"25","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0006-2952(01)00790-0","article-title":"Effect of atorvastatin, simvastatin, and lovastatin on the metabolism of cholesterol and triacylglycerides in HepG2 cells","volume":"62","author":"M\u00e4rz","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"26","first-page":"582","article-title":"Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)","volume":"81","author":"Hunninghake","year":"1998","journal-title":"The American Journal of Cardiology"},{"key":"27","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.cardiores.2006.08.019","article-title":"Cardiovascular benefits of omega-3 fatty acids","volume":"73","author":"Harris","year":"2007","journal-title":"Cardiovascular Research"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Zhang, Liu, Li, Xu, Sun, Li. Impact of currently prescribed lipid-lowering drugs on plasma PCSK9 concentration: single or in combination study in rats. Lipids in health and disease. 2014; 13:35.","DOI":"10.1186\/1476-511X-13-35"},{"key":"29","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1161\/01.ATV.0000134621.14315.43","article-title":"Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated conveitase-1 implicated in familial hypercholesterolemia","volume":"24","author":"Prat","year":"2004","journal-title":"Arterioscler Thromb Vase Biol"},{"key":"30","first-page":"1493","article-title":"The therapeutic effects of combination of simvastatin with berberine on the patients with hyperlipemia","volume":"29","author":"Zhang","year":"2009","journal-title":"ACTA Unieversitys Medicinalis Nanjing (Natural Science)"},{"key":"31","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.amjcard.2008.02.056","article-title":"Effect of Xuezhikang,an extract from red yeast Chinese rice on coronary events in a Chinese population with previous myocardial infarction","volume":"101","author":"Li","year":"2008","journal-title":"Am J Cardiol"},{"key":"32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/07853891003652534","article-title":"Impact of Xuezhikang on coronary events in hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS)","volume":"42","author":"Zhao","year":"2010","journal-title":"Ann Med"},{"key":"33","first-page":"387","article-title":"Research and application progress of red yeast rice for lowering the blood cholesterol level","volume":"35","author":"Wu","year":"2014","journal-title":"Science and Technology of Food Industry"},{"key":"34","first-page":"248","article-title":"Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature","volume":"6","author":"Uzick","year":"2001","journal-title":"Altern Med Rev"},{"key":"35","first-page":"316","article-title":"Research on the chemical components and pharmacological effects of hawthorn","volume":"33","author":"Lu","year":"2010","journal-title":"Drug Evaluation Research"},{"key":"36","first-page":"92","article-title":"Reviews of pharmacological studies on alismatis","volume":"23","author":"Lin","year":"2011","journal-title":"Strait Pharmaceutical Journal"},{"key":"37","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jacl.2014.03.004","article-title":"An assessment by the Statin Muscle Safety Task Force: 2014 update","volume":"8","author":"Parker","year":"2014","journal-title":"Journal of Clinical Lipidology"},{"key":"38","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","article-title":"Statin-associated muscle symptoms: impact on statin therapy\u2014European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management","volume":"36","author":"Krauss","year":"2015","journal-title":"European Heart Journal"},{"key":"39","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1126\/science.1168974","article-title":"LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor","volume":"325","author":"Tontonoz","year":"2009","journal-title":"Science"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.18329","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T11:32:44Z","timestamp":1589023964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.18329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,1]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,2,6]]}},"alternative-id":["18329","29507705"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.18329","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,1]]}}}